| 摘要 |
The invention relates to novel biphenyl derivatives of general formula (I) wherein Y, R, R<1>, R<2>, R<3>, R<4>, m, o and p have the designation cited in patent claim 1; and the physiologically tolerable salts or solvates thereof. Said derivatives are integrin inhibitors and can be used to combat thrombosis, infarction, coronary heart disease, arteriosclerosis, inflammation, tumours, osteoporosis, infection and restenosis after angioplasty, or in pathological processes which are maintained or spread by angiogenesis.
|
